SCNX Earnings Date: Nov 11, 2026 (Estimated) — Scienture Holdings, Inc.
NASDAQ · Healthcare · Pharmaceutical Retailers
Updated
When is SCNX's next earnings date?
Scienture Holdings, Inc. (SCNX) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.57 on revenue of $1.2M.
How did SCNX do in its last earnings report?
In its most recent report on Aug 14, 2026 (Q2 2026), Scienture Holdings, Inc. posted EPS of -$1.75 versus the -$2.25 estimate, a beat of 22.2%. Revenue was $343,639. The stock's 1-day post-earnings move was -1.3%.
How much does SCNX stock move after earnings?
SCNX beat EPS estimates in 3 of its last 4 reported quarters. Over the last 8 reports the stock moved an average of 7.4% (up or down) in the day after earnings.
About Scienture Holdings, Inc.
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | Q2 2026 | -2.25 | -1.75 | +22.22% | $343,639 | ✅ Beat | -1.29% | +1.89% | -27.15% |
| 2026-08-13 | -2.25 | -1.75 | +22.22% | $343,639 | ✅ Beat | +2.04% | +5.33% | -22.68% | |
| 2026-05-15 | Q1 2026 | -5.50 | -2.00 | +63.64% | $56,325 | ✅ Beat | -2.33% | -0.25% | -5.21% |
| 2026-03-30 | Q4 2025 | -7.00 | -44.00 | -528.57% | $-168,699 | ❌ Miss | -42.23% | -21.65% | -8.18% |
| 2025-11-13 | Q3 2025 | — | -4.75 | — | $590,050 | — | -5.47% | -17.76% | -14.86% |
| 2025-08-12 | Q2 2025 | — | -12.00 | — | $0 | — | -1.42% | -44.34% | -58.02% |
| 2025-03-26 | Q4 2024 | — | -19.00 | — | $53,083 | — | -3.39% | -24.29% | -46.33% |
| 2024-08-09 | Q2 2024 | — | -29.00 | — | $18.7M | — | +0.63% | +31.60% | +3.14% |
Showing last 8 quarters.